New hope for tough brain tumors: targeted radiation trial launches

NCT ID NCT06326190

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a drug called 177Lu-DOTATATE for people with recurrent meningioma, a type of brain tumor that has come back after surgery or radiation. The drug delivers radiation directly to tumor cells by targeting a protein found on these tumors. About 136 adults will be randomly assigned to receive the drug or standard care, and researchers will track how long the tumor stays under control.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT MENINGIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • A.O Landeskrankenhaus - Innsbruck Universitaetsklinik

    RECRUITING

    Innsbruck, 6020, Austria

  • Assistance Publique - Hopitaux de Marseille APHM - Hopital de La Timone (APHM)

    RECRUITING

    Marseille, 13005, France

  • CHRU de Nancy - Hopitaux De Brabois

    RECRUITING

    Vandœuvre-lès-Nancy, 54511, France

  • CHU de Lyon - CHU Lyon - Hopital neurologique Pierre Wertheimer

    RECRUITING

    Lyon, 69500, France

  • CHU de Toulouse - Institut Claudius Regaud - IUCT oncopole

    RECRUITING

    Toulouse, 31100, France

  • Centre Eugene Marquis

    RECRUITING

    Rennes, 35042, France

  • Centre Leon Berard

    RECRUITING

    Lyon, 69008, France

  • Gustave Roussy

    RECRUITING

    Villejuif, 94805, France

  • Hospital Universitario 12 De Octubre

    RECRUITING

    Madrid, 28041, Spain

  • Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern

    RECRUITING

    München, 81377, Germany

  • Oncology Institute of Southern Switzerland (IOSI) - Ospedale San Giovanni

    NOT_YET_RECRUITING

    Bellinzona, 6500, Switzerland

  • Oslo University Hospital - Radiumhospitalet

    RECRUITING

    Oslo, 0379, Norway

  • St Olavs University Hospital - St. Olavs Hospital, Trondheim University Hospital

    RECRUITING

    Trondheim, 7030, Norway

  • UniversitaetsSpital Zurich - Neurology Clinic

    NOT_YET_RECRUITING

    Zurich, 8091, Switzerland

  • Universitaetskliniken der Uni Wien - Universitaetsklinikum Wien - AKH unikliniken

    RECRUITING

    Vienna, 1090, Austria

  • Universitaetsklinikum - Essen

    RECRUITING

    Essen, 45147, Germany

  • Universitaetsklinikum Heidelberg - UniversitaetsKlinikum Heidelberg - Head Hospital

    RECRUITING

    Heidelberg, 69120, Germany

  • University Frankfurt - Goethe Univ. - University Hospital Frankfurt- Klinik für Neurologie Funktionsbereich Neuroonkologie

    RECRUITING

    Frankfurt, 60590, Germany

  • Vall D Hebron - Hospital Universitari Vall d'Hebron -Vall d'Hebron Institut Oncologia

    RECRUITING

    Barcelona, 08035, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.